New oral drug for inflammatory bowel disease enters first human tests
NCT ID NCT07632573
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests BDHK-2009, an experimental tablet for inflammatory bowel diseases like ulcerative colitis and Crohn's disease. The study involves 68 healthy adults aged 18 to 55 to see if the drug is safe and how the body handles it. Participants receive either a single dose or multiple doses of the drug or a placebo, with close monitoring for side effects and drug levels in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BDHK-2009
- What this could lead to
- If safe and effective in later trials, BDHK-2009 could become a new oral treatment option for people with ulcerative colitis or Crohn's disease.
- What could go wrong
- This is a very early Phase 1 study in healthy volunteers, not patients. It only tests safety and how the drug moves through the body, not whether it works for the disease. Many drugs fail in later stages.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CD - CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhejiang Xiaoshan Hospital
RECRUITINGHangzhou, Zhejiang, 311200, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- Tailored therapy may save colons in severe ulcerative colitis
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Can a new pill tame ulcerative colitis Flare-Ups?
- Can a mediterranean diet and Time-Restricted eating tame gut inflammation?
- Could a new pill tame ulcerative colitis? a First-in-Human trial aims to find out